Gamma Knife Radiosurgery: How It Works, What It Treats, Risks and Results
By Ruth Alderman | Medically reviewed by Mr Edward Halloran, FRCS (SN)
Published June 12, 2026 · Last reviewed June 19, 2026 · 7 min read
Key takeaways
- Gamma Knife is a form of stereotactic radiosurgery: many weak beams of cobalt-60 gamma radiation converge on a target in the brain, so it is not surgery and involves no incision.
- It treats acoustic neuromas, meningiomas, brain metastases, arteriovenous malformations, trigeminal neuralgia and pituitary tumours, usually in a single day-case session.
- The dose is planned by a team (a neurosurgeon, a radiation oncologist and a physicist), and the treatment is done while you are awake, with the frame removed the same day.
- It works slowly: the target usually stays visible on scans, and control rather than disappearance is the aim, over months to a few years depending on the condition.
- The most important delayed risk is radiation necrosis, roughly 5 to 25% depending on size and dose; serious harm is uncommon and the treatment is planned to avoid it.
Gamma Knife is a form of stereotactic radiosurgery in which many weak beams of cobalt-60 gamma radiation converge on a target in the brain, delivering a high dose there while sparing the tissue around it. Despite the name it is not surgery: there is no incision and no knife. It treats acoustic neuromas, meningiomas, brain metastases, arteriovenous malformations, trigeminal neuralgia and pituitary tumours, usually in a single day-case session while you are awake1.
When my own acoustic neuroma was found, the word radiosurgery meant nothing to me, and the explanations I found stopped at “non-invasive” and “painless”. What I actually wanted was the real shape of it: how the beams work, whether my tumour even qualified, what the frame felt like, and why nobody could tell me on the day whether it had worked. This is the account I went looking for. If you want the physics in full, read how Gamma Knife works; if you are wondering whether it is even an option, start with am I a candidate for Gamma Knife.
What is Gamma Knife radiosurgery?
Gamma Knife is a machine that delivers stereotactic radiosurgery to the brain: it focuses about 192 individually weak beams of cobalt-60 gamma radiation so they meet at one point, where together they add up to a treatment dose. Each beam on its own is too weak to harm the tissue it passes through; only where they converge is the dose high. That is how a high dose reaches a target a few millimetres across while the healthy brain around it is largely spared2.
It is made by Elekta as the Leksell Gamma Knife, named after the neurosurgeon Lars Leksell, who proposed the idea in 1968. Current models use 192 sources; older units used 201, which is why you see both numbers. The word radiosurgery describes a single high dose; when the same idea is split into a few sessions it is called stereotactic radiotherapy3.
How Gamma Knife works
Gamma Knife works by aiming many low-intensity gamma beams from fixed cobalt-60 sources through a collimator, so they cross at the target and deliver their combined dose there. The beams converge to an accuracy of under about half a millimetre, which is what makes it possible to treat something sitting right next to a nerve or a blood vessel. A treatment plan may combine several of these convergence points, called isocentres, to match the shape of an awkward target.
The precision is the whole point, and it is also why the day is built around imaging and planning rather than around an operation. For the step-by-step version, see how Gamma Knife works and frame-based versus frameless radiosurgery.
What Gamma Knife treats
Gamma Knife is used for a defined set of conditions where a small, well-seen target can be dosed without opening the skull. The common ones, each with its own article, are:
- Acoustic neuroma (vestibular schwannoma): 5-year tumour control of roughly 90 to 99%, with hearing preservation that varies widely, around 40 to 80%, depending on tumour size and follow-up. See Gamma Knife for acoustic neuroma.
- Meningioma (benign, grade I): 5-year local control of roughly 85 to 100%. See Gamma Knife for meningioma.
- Brain metastases: 1-year local control of roughly 70 to 90%, strongly dependent on the dose, and often chosen over whole-brain radiotherapy to spare memory and thinking, in line with national guidance4. See Gamma Knife for brain metastases.
- Arteriovenous malformation (AVM): closure (obliteration) of roughly 65 to 90% over a latency of 2 to 3 years. See Gamma Knife for AVM.
- Trigeminal neuralgia: initial pain relief of roughly 70 to 90%, coming on over a median of about 2 months. See Gamma Knife for trigeminal neuralgia.
- Pituitary adenoma: tumour control over 90%. See Gamma Knife for pituitary adenoma.
For the overview of how these fit together, see what Gamma Knife treats.
Am I a candidate for Gamma Knife?
Suitability depends on the size, position and type of the target, not on preference, and it is decided by a team looking at your scans. As a rule of thumb, single-session radiosurgery suits targets around 3 to 3.5 cm or smaller (about 10 to 15 cc in volume). Larger ones are usually treated with surgery, or with the dose split over several sessions5. The main considerations are:
- Size: small enough to dose safely in one session, or else staged over a few.
- Position: targets very close to the optic nerves or brainstem may be fractionated to protect them.
- Number: older guidance capped brain metastases at about four per session; modern practice treats more, guided by the total tumour volume.
- The alternative on the table: whether surgery is needed instead, for example to relieve pressure quickly or to get a tissue diagnosis.
I assumed radiosurgery was automatically the gentler and therefore better choice; in fact the team weighed it against watching and waiting and against surgery before recommending it. For the detail, see am I a candidate for Gamma Knife and Gamma Knife versus surgery.
The day: frame, planning and treatment
The day runs in four steps: fitting the frame, imaging, planning the dose, then the treatment itself, and you are awake for all of it. For frame-based treatment a lightweight frame is fixed to the skull with four pins after four injections of local anaesthetic; you feel pressure rather than pain. Then comes an MRI or CT (an angiogram for an AVM) taking about 30 minutes, followed by the part nobody warns you about: a wait of one to several hours while the team plans the dose around your anatomy. The treatment that follows takes about 30 minutes to 2 hours5.
The long middle wait was the strangest part of my day, sitting with a frame on my head while people I could not see worked out exactly where the beams would go. See the day in the Gamma Knife frame and what the frame feels like for the honest version.
Risks and side effects
Early side effects are usually mild and short-lived; the effect that matters most is a delayed one, radiation necrosis, and the plan is built to keep it unlikely. No treatment that delivers a high dose of radiation is free of risk. The ones worth naming plainly are:
- Fatigue and headache: common in the first hours to weeks, usually mild.
- Pin-site soreness: brief, frame-based treatment only, uncommon.
- Temporary hair thinning near the treated area, with regrowth over about 2 to 3 months.
- Brain swelling (oedema): managed with corticosteroids.
- Radiation necrosis: the important delayed risk, roughly 5 to 25% depending on the size of the target and the dose, and often treatable.
- Cranial-nerve effects such as hearing change, for targets near those nerves.
The rare question people ask about, a second tumour caused by the radiation, is real but on the order of well under 1% over many years1. For the full picture, see Gamma Knife risks and side effects and radiation necrosis, what I learned.
Recovery and follow-up
Most people go home the same or next day and are back to normal activity within a day or two, but the result takes months to years to show, so follow-up scans matter more than how you feel. The frame comes off straight after treatment. What is harder to sit with is that radiosurgery works slowly: benign tumours change over 1 to 3 years, AVMs close over 2 to 3 years, and the target usually stays visible on scans. Control, not disappearance, is the aim3.
Follow-up is typically an office visit at about a month, then MRIs at 3, 6 and 12 months, spacing out after that. I found the waiting between scans harder than the treatment itself, which is a common experience: see radiosurgery and scanxiety and Gamma Knife results and follow-up.
How much does Gamma Knife cost?
In the United States self-pay figures run roughly $12,000 to $55,000 all-in, and in the UK privately it is commonly £10,000 to £25,000; it is widely covered by insurance or the NHS when it is clinically indicated. One analysis of US cancer centres found a median around $49,500, and radiosurgery generally costs well below open surgery. On the NHS it is fully funded once a multidisciplinary team approves it through specialist referral, with no extra charge to the patient. For the breakdown, see how much does Gamma Knife cost.
Gamma Knife and the alternatives
Gamma Knife is one tool among several, and the right one depends on the target, not on the brand name. If the lesion is large or needs a tissue diagnosis, surgery may be the answer: see Gamma Knife versus surgery. If you are comparing machines, the practical differences with the robotic, frameless system are covered in Gamma Knife versus CyberKnife. And for brain metastases, the choice between focused treatment and treating the whole brain is set out in Gamma Knife versus whole-brain radiotherapy.
References
- Stereotactic Radiosurgery, American Association of Neurological Surgeons. ↩
- Gamma Knife Treatment, Elekta. ↩
- Stereotactic radiotherapy for brain and spinal cord tumours, Cancer Research UK. ↩
- Brain tumours (primary) and brain metastases in over 16s (NG99), NICE. ↩
- Gamma Knife Surgery, Cleveland Clinic. ↩
Common questions
Is Gamma Knife actually surgery?
No. Despite the name, Gamma Knife involves no incision and no knife. It is a form of stereotactic radiosurgery: about 192 weak beams of cobalt-60 gamma radiation (201 in older units) are aimed so they converge on a target in the brain, delivering a high dose there while sparing the tissue around it. You are awake throughout and go home the same day.
How long does Gamma Knife take?
It is usually a single day-case session. Imaging takes around 30 minutes, planning the dose takes one to several hours while you wait, and delivering the treatment takes about 30 minutes to 2 hours depending on the target. Most people are in and out in a day, with the frame removed straight afterwards.
Does Gamma Knife get rid of the tumour straight away?
No, and this surprises many people. Radiosurgery works gradually. The target usually stays visible on follow-up scans, and the goal is control, meaning it stops growing, rather than disappearance. Benign tumours change slowly over 1 to 3 years, AVMs close over 2 to 3 years, and trigeminal pain eases over days to about 2 months.
What conditions can Gamma Knife treat?
The common ones are acoustic neuroma (vestibular schwannoma), meningioma, brain metastases, arteriovenous malformations, trigeminal neuralgia and pituitary tumours. It is used for targets that are small enough, generally 3 to 3.5 cm or less, and in the right position. Larger targets are usually treated with surgery or with the dose split over several sessions.
What are the main risks of Gamma Knife?
Early effects are usually mild: fatigue, headache and, for frame-based treatment, brief pin-site soreness. The most important delayed effect is radiation necrosis, roughly 5 to 25% depending on the size and dose, along with some brain swelling that is managed with steroids. Serious harm is uncommon and the plan is designed to keep the dose to healthy tissue low.
How much does Gamma Knife cost?
In the United States, self-pay figures run roughly $12,000 to $55,000 all-in, and it is widely covered by insurance when it is clinically indicated. In the UK it is commonly £10,000 to £25,000 privately, and on the NHS it is fully covered once a multidisciplinary team approves it through specialist referral.
Written by Ruth Alderman. Medically reviewed by Mr Edward Halloran, FRCS (SN).
Our guides are written from personal experience and reviewed by a qualified clinician for accuracy. Read our editorial policy.